IT9020295A0 - PROCEDURE FOR DOSING IGG ANTI-BODIES, SPECIFIC ANTI-ALLERGENS, FRACTION RICH IN IHG4 OBTAINED ACCORDING TO THIS PROCEDURE AND PHARMACEUTICAL COMPOSITION CONTAINING THIS FRACTION - Google Patents

PROCEDURE FOR DOSING IGG ANTI-BODIES, SPECIFIC ANTI-ALLERGENS, FRACTION RICH IN IHG4 OBTAINED ACCORDING TO THIS PROCEDURE AND PHARMACEUTICAL COMPOSITION CONTAINING THIS FRACTION

Info

Publication number
IT9020295A0
IT9020295A0 IT9020295A IT2029590A IT9020295A0 IT 9020295 A0 IT9020295 A0 IT 9020295A0 IT 9020295 A IT9020295 A IT 9020295A IT 2029590 A IT2029590 A IT 2029590A IT 9020295 A0 IT9020295 A0 IT 9020295A0
Authority
IT
Italy
Prior art keywords
procedure
fraction
ihg4
allergens
dosing
Prior art date
Application number
IT9020295A
Other languages
Italian (it)
Other versions
IT9020295A1 (en
Inventor
Patrick Lambin
Clothilde Bremard-Oury
Original Assignee
Fond Nat Transfusion Sanguine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fond Nat Transfusion Sanguine filed Critical Fond Nat Transfusion Sanguine
Publication of IT9020295A0 publication Critical patent/IT9020295A0/en
Publication of IT9020295A1 publication Critical patent/IT9020295A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
IT020295A 1989-05-12 1990-05-14 DETERMINATION PROCEDURE FOR IGG ANTI-BODIES SPECIFIC ANTI-ALLERGENS, A FRACTION RICH IN IHG4 OBTAINED ACCORDING TO THIS PROCEDURE AND PHARMACEUTICAL COMPOSITION CONTAINING THIS FRACTION IT9020295A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8906281A FR2646917A1 (en) 1989-05-12 1989-05-12 METHOD FOR DETERMINING ANTI-ALLERGEN SPECIFIC IGG ANTI-BODY, IGG4-RICH FRACTION OBTAINED ACCORDING TO THIS PROCESS AND PHARMACEUTICAL COMPOSITION CONTAINING THIS FRACTION

Publications (2)

Publication Number Publication Date
IT9020295A0 true IT9020295A0 (en) 1990-05-14
IT9020295A1 IT9020295A1 (en) 1990-11-13

Family

ID=9381627

Family Applications (1)

Application Number Title Priority Date Filing Date
IT020295A IT9020295A1 (en) 1989-05-12 1990-05-14 DETERMINATION PROCEDURE FOR IGG ANTI-BODIES SPECIFIC ANTI-ALLERGENS, A FRACTION RICH IN IHG4 OBTAINED ACCORDING TO THIS PROCEDURE AND PHARMACEUTICAL COMPOSITION CONTAINING THIS FRACTION

Country Status (3)

Country Link
FR (1) FR2646917A1 (en)
IT (1) IT9020295A1 (en)
WO (1) WO1990013817A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5367054A (en) * 1993-04-12 1994-11-22 Stolle Research & Development Corp. Large-scale purification of egg immunoglobulin
BRPI0800612A2 (en) * 2008-01-02 2009-08-25 Fundacao Fapemig Method and Kit for Quantifying Allergen-Specific Human IgG Subclasses for Follow-Up of Specific Immunotherapy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60228421A (en) * 1984-04-27 1985-11-13 Shionogi & Co Ltd Monoclonal anti-human-igg antibody and its preparation
DE3586787T2 (en) * 1984-05-11 1993-06-03 Biowhittaker Inc FLUORESCENCE TEST FOR IGG4.
FR2578425B1 (en) * 1985-03-07 1988-06-10 Nal Transfusion Sanguine Centr IMMUNOGLOBULIN PREPARATIONS HAVING HIGH TITLES OF ANTI-ALLERGENIC BLOCKING ANTIBODIES, THEIR PREPARATION AND THEIR APPLICATIONS FOR THE TREATMENT OF ALLERGIES
JPS61286754A (en) * 1985-06-12 1986-12-17 Shionogi & Co Ltd Monoclonal anti-human igg4 antibody and its preparation

Also Published As

Publication number Publication date
FR2646917A1 (en) 1990-11-16
WO1990013817A1 (en) 1990-11-15
IT9020295A1 (en) 1990-11-13

Similar Documents

Publication Publication Date Title
IL105541A0 (en) Monoclonal antibodies to gp130 protein,processes for the preparation thereof and pharmaceutical compositions containing the same
FI943565A (en) Novel anticoagulant polypeptides, their preparation and pharmaceutical composition containing them
IL78444A (en) Human gamma interferon-specific receptor protein,antibody against said protein,and compositions containing said protein and antibody
NZ228564A (en) Corticosteroid-containing skin care composition for use as moisturiser: preparation thereof
IT8367315A0 (en) TOPICAL PHARMACEUTICAL COMPOSITION FOR OPHTHALMIC USE AND ITS APPLICATION
EP0155387A3 (en) Fibronolytically active hybrid protein, process for its preparation and pharmaceutical composition
IL69198A (en) N-(bicyclic heterocyclyl)-4-piperidinamines,their preparation and pharmaceutical compositions containing them
ZA908521B (en) Vaccine composition with non-immunosuppressive t cell epitope component
NO171223C (en) MONOCLONAL RECEPTOR MOLECULE OR PART THEREOF INCLUDING THE ANTIBODY BINDING SITE, FOR IN VITRO USE, AND IN VITRO USE thereof
NZ221440A (en) Composition containing monoclonal antibodies/peptides useful in treating and diagnosing hiv infections
DE68928846D1 (en) Bottle spa powder composition
GB2186592B (en) Cross-protective human monoclonal antibody compositions
FR2632545B1 (en) APPLICATOR FOR VISCOUS MASS, PREFERABLY COSMETIC
IT9020295A0 (en) PROCEDURE FOR DOSING IGG ANTI-BODIES, SPECIFIC ANTI-ALLERGENS, FRACTION RICH IN IHG4 OBTAINED ACCORDING TO THIS PROCEDURE AND PHARMACEUTICAL COMPOSITION CONTAINING THIS FRACTION
IL77990A (en) Monoclonal anti-alpha-amylase antibody,process for obtaining the same and pharmaceutical compositions containing the same
DK138084A (en) BOND CLOSED COMPOSITION, PRIOR TO PHARMACEUTICAL CONTAINERS
AU591579B2 (en) Antibodies for use in determining human glycoalbumin
AU8168887A (en) Monoclonal antibodies effective in promoting growth
IL83342A0 (en) Monoclonal antibodies,their preparation and their use
EP0205046A3 (en) Monoclonal antibody to human protein c
AU5217890A (en) Monoclonal antibodies in vaccine formulations
EP0407586A4 (en) Human monoclonal antibody and process for its preparation
KR900019778U (en) Cosmetic container with dropper
FR2608926B1 (en) BABESIA DIVERGENS ANTIGEN, PROCESS FOR PRODUCING THE SAME, AND VACCINE CONTAINING THE SAME
DK346387A (en) PROCEDURE FOR REDUCING THE ALKALIA CONTENT IN CEMENT CLINKS

Legal Events

Date Code Title Description
0002 Rejected